Bridgeway Capital Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $26.6K | Hold |
|
|||||
|
2022
Q4 | $21.5K | Hold |
|
|||||
|
2022
Q3 | $26K | Hold |
|
|||||
|
2022
Q2 | $74K | Hold |
|
|||||
|
2022
Q1 | $81K | Hold |
|
|||||
|
2021
Q4 | $102K | Hold |
|
|||||
|
2021
Q3 | $179K | Hold |
|
|||||
|
2021
Q2 | $187K | Sell |
|
|||||
|
2021
Q1 | $409K | Buy |
|
|||||
|
2020
Q4 | $236K | Sell |
|
|||||
|
2020
Q3 | $358K | Buy |
|
|||||
|
2020
Q2 | $246K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $20K | Hold |
|
|||||
|
2018
Q2 | $20K | Sell |
|
|||||
|
2018
Q1 | $234K | Hold |
|
|||||
|
2017
Q4 | $233K | Hold |
|
|||||
|
2017
Q3 | $270K | Hold |
|
|||||
|
2017
Q2 | $331K | Hold |
|
|||||
|
2017
Q1 | $375K | Hold |
|
|||||
|
2016
Q4 | $408K | Hold |
|
|||||
|
2016
Q3 | $595K | Hold |
|
|||||
|
2016
Q2 | $345K | Hold |
|
|||||
|
2016
Q1 | $614K | Hold |
|
|||||
|
2015
Q4 | $864K | Hold |
|
|||||
|
2015
Q3 | $1.48M | Hold |
|
|||||
|
2015
Q2 | $1.05M | Hold |
|
|||||
|
2015
Q1 | $1.03M | Sell |
|
|||||
|
2014
Q4 | $1.4M | Buy |
|
|||||
|
2014
Q3 | $649K | Hold |
|
|||||
|
2014
Q2 | $728K | Buy |
|
|||||
|
2014
Q1 | $881K | Buy |
|